Fairvalue-Calculator Fairvalue-Calculator
EN DE

Qing Song Health Co (6931) Fair Value & Analysis

Healthcare · TW · Market cap 2.7B TWD

Price40.20 TWD
Fair Value27.73 TWD
Upside-31.0%
Quality94/100
Evidence: High Range 14.23 TWD – 34.66 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Qing Song Health Co (6931) currently trades at 40.20 TWD, while our model-based Fair Value estimate is 27.73 TWD — implying the stock looks roughly 31.0% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Qing Song Health Co.,Ltd. provides long-term care services in Taiwan. It offers community-based and residential long-term care services, providing home, and community to residential and other diversified care. The company was founded in 1996 and is based in Taichung, Taiwan.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +19% Fresenius SE (FSNUY) -27% 5225 (5225) -39% IHHHF (IHHHF) -26% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +86%

Frequently asked questions

Is Qing Song Health Co (6931) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 27.73 TWD versus a price of 40.20 TWD — about −31% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 6931?
Our 21-model fair value for Qing Song Health Co is 27.73 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 40.20 TWD.
What is the quality score of 6931?
Qing Song Health Co has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.